Pedro Roda-Navarro

8PUBLICATIONS
40CO-AUTHORS
Molecular targetsHaematological tumoursMechanobiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cell physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 22, 2025
Selective genome editing of amplified oncogenes triggers immunogenic cell death and tumor remodeling.

A Nieto-Sanchez, M Martinez-Lage, P Puig-Serra

|Jul 30, 2024
Human T-cell receptor triggering requires inactivation of Lim kinase-1 by Slingshot-1 phosphatase.

Álvaro Gómez-Morón, Sergio Alegre-Gómez, Rocio Ramirez-Muñoz

|May 19, 2022
Altered CXCR4 dynamics at the cell membrane impairs directed cell migration in WHIM syndrome patients.

Eva M García-Cuesta, José Miguel Rodríguez-Frade, Sofía R Gardeta

|Mar 31, 2022
Synapse topology and downmodulation events determine the functional outcome of anti-CD19 T cell-redirecting strategies.

Ángel Ramírez-Fernández, Óscar Aguilar-Sopeña, Laura Díez-Alonso

|Feb 14, 2022
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer.

Antonio Tapia-Galisteo, Íñigo Sánchez Rodríguez, Oscar Aguilar-Sopeña

|Jan 30, 2018
Corrigendum to "Gene Expression Profiles of Human Phosphotyrosine Phosphatases Consequent to Th1 Polarisation and Effector Function".

Patricia Castro-Sánchez, Rocio Ramirez-Munoz, Pedro Roda-Navarro

Pageof 2